Literature DB >> 26312426

Alzheimer's Disease associated with Psychiatric Comorbidities.

Michelle L Garcez1, Ana Carolina B Falchetti1, Francielle Mina1, Josiane Budni1.   

Abstract

Alzheimer's disease (AD) is the most common cause of dementia and has become a severe public health issue. It is estimated that globally, 35.6% of people have some form of dementia. This number is expected to double by 2030, and possibly even triple by 2050. The disease is associated with deficits in cognition/memory and a reduced ability in coping with everyday life. Moreover, patients can experience behavioral alterations such as mood swings, depression and hallucinations. Therefore, it is common to find the presence of neuropsychiatric comorbidities such as depression, schizophrenia and bipolar disorder during the course or development of AD. These disorders can become severe enough to interfere with the patients daily functioning, and can worsen the course of the disease. However, little is known about the causal relationship between psychiatric comorbidities and AD, or the reasons for the predisposition of some individuals to such disorders. Therefore, the purpose of this review is to clarify the causal relationship between depression, schizophrenia and bipolar disorder with AD.

Entities:  

Mesh:

Year:  2015        PMID: 26312426     DOI: 10.1590/0001-3765201520140716

Source DB:  PubMed          Journal:  An Acad Bras Cienc        ISSN: 0001-3765            Impact factor:   1.753


  9 in total

1.  11,12-Diacetyl-carnosol Protects SH-SY5Y Cells from Hydrogen Peroxide Damage through the Nrf2/HO-1 Pathway.

Authors:  Qingyi Luo; Weiyan Hu; Haofei Yu; Rongping Zhang; Xinglong Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-17       Impact factor: 2.650

2.  A Genetic Model of Epilepsy with a Partial Alzheimer's Disease-Like Phenotype and Central Insulin Resistance.

Authors:  Suélen Santos Alves; Rui Milton Patrício da Silva Junior; Polianna Delfino-Pereira; Marilia Gabriella Alves Goulart Pereira; Israel Vasconcelos; Hanna Schwaemmle; Rodrigo Focosi Mazzei; Maiko Luiz Carlos; Enilza Maria Espreafico; Antônio Claudio Tedesco; Adriano Sebollela; Sebastião Sousa Almeida; José Antônio Cortes de Oliveira; Norberto Garcia-Cairasco
Journal:  Mol Neurobiol       Date:  2022-04-04       Impact factor: 5.682

3.  A human carboxypeptidase E/NF-α1 gene mutation in an Alzheimer's disease patient leads to dementia and depression in mice.

Authors:  Y Cheng; N X Cawley; T Yanik; S R K Murthy; C Liu; F Kasikci; D Abebe; Y P Loh
Journal:  Transl Psychiatry       Date:  2016-12-06       Impact factor: 6.222

4.  The Alzheimer's comorbidity phenome: mining from a large patient database and phenome-driven genetics prediction.

Authors:  Chunlei Zheng; Rong Xu
Journal:  JAMIA Open       Date:  2018-12-19

5.  Antipsychotic treatment effects on cardiovascular, cancer, infection, and intentional self-harm as cause of death in patients with Alzheimer's dementia.

Authors:  R-E Nielsen; A Lolk; J-B Valentin; K Andersen
Journal:  Eur Psychiatry       Date:  2016-12-12       Impact factor: 5.361

6.  Big Data Analysis of Genes Associated With Neuropsychiatric Disorders in an Alzheimer's Disease Animal Model.

Authors:  Suji Ham; Tae K Kim; Heeok Hong; Yong S Kim; Ya-Ping Tang; Heh-In Im
Journal:  Front Neurosci       Date:  2018-06-15       Impact factor: 4.677

Review 7.  Connexin43- and Pannexin-Based Channels in Neuroinflammation and Cerebral Neuropathies.

Authors:  Denis Sarrouilhe; Catherine Dejean; Marc Mesnil
Journal:  Front Mol Neurosci       Date:  2017-10-10       Impact factor: 5.639

8.  Prevalence of Comorbidities in Individuals Diagnosed and Undiagnosed with Alzheimer's Disease in León, Spain and a Proposal for Contingency Procedures to Follow in the Case of Emergencies Involving People with Alzheimer's Disease.

Authors:  Macrina Tortajada-Soler; Leticia Sánchez-Valdeón; Marta Blanco-Nistal; José Alberto Benítez-Andrades; Cristina Liébana-Presa; Enrique Bayón-Darkistade
Journal:  Int J Environ Res Public Health       Date:  2020-05-13       Impact factor: 3.390

9.  Microarray analysis of verbenalin-treated human amniotic epithelial cells reveals therapeutic potential for Alzheimer's Disease.

Authors:  Farhana Ferdousi; Shinji Kondo; Kazunori Sasaki; Yoshiaki Uchida; Nobuhiro Ohkohchi; Yun-Wen Zheng; Hiroko Isoda
Journal:  Aging (Albany NY)       Date:  2020-03-29       Impact factor: 5.955

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.